Tuesday, June 19, 2012

'Closed Door Reception' 5:00PM - 7:00PM Massachusetts Statehouse

Hank Paulson at Closed Door 'Reception' 5:00PM - 7:00PM with MA state legislators? We protest at the statehouse starting 4:30PM. 'Banks got bailed out we got sold out'


"The architect of our demise" Hank Paulson is the keynote speaker at today's luncheon for the International BIO convention.  Little known fact, key sponsors of BIO 2012 will be meeting at the statehouse from 5:00PM - 7:00PM with members of MA state legislature Paulson is rumored to be in attendance. 

Whywalkabout, LEAH Advocacy Group, and members of Occupy Boston will be at the Massachusetts Statehouse to protest the use of our public buildings for closed door meetings between the legislature and big money sponsors. 

We are gathering at the Civil Memorial statue across from the statehouse steps at 4:30PM to form our "welcoming party". 

"Henry Paulsen, ex-Goldman Sachs CEO, and a major architect, of the transfer of $700 billion in taxpayer money to Sachs and other major banks, has been chosen as a keynote speaker for the June 18-21 international Biotechnology Industry Organization convention in Boston. Paulsen will be discussing the importance of "balancing austerity (presumably for the majority) and growth (for corporate and wealthy interests)" with fellow ex-Secretary of the Treasury Robert Rubin. While many Americans are calling for the prosecution of Paulsen, whose net worth has been estimated as approximately $700 million, for his extensive record of  corporate crime, the biotech industry has chosen to align itself with him and his notoriously destructive views and policy stances." - Jeffery Levy

Sponsors that may be attending:

Georgia, USA - The Georgia Department of Economic Development (GDEcD) is the state's sales and marketing arm and lead agency for attracting new business investment, encouraging the expansion of existing industry and small businesses, developing new domestic and international markets, attracting tourists to Georgia, and promoting the state as a location for film, video, music and digital entertainment projects, as well as planning and mobilizing state resources for economic development.

Pfizer -  Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That's why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them.

Human Genome Sciences - At Human Genome Sciences, we believe that solving critical medical challenges takes careful planning, relentless resilience, the best scientific minds, and rigorous clinical trials. Success will come by design – and by working systematically to achieve breakthrough results one careful step at a time.

Janssen Pharmaceuticals, Inc. -  (a Johnson & Johnson Company) - Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.

MedImmune - Clearly positioned among the world's leading biotechnology companies, MedImmune has leveraged its own organic growth, and has also expanded through the key acquisitions of U.S. Bioscience in 1999 and Aviron in 2002, as well as the integration with Cambridge Antibody Technology and the strategic alignment with our new parent company, AstraZeneca, in 2007. Our rapid expansion is also attributable to the activities of our business development department, responsible for actions such as strategic in-licensing, and to the launch of MedImmune Ventures Inc., a wholly-owned capital venture fund.

Mintz Levin - (Mintz Levin Cohn Ferris Glovsky and Popeo PC) Founded in 1933, Mintz Levin has grown into a versatile law firm of 500 highly qualified and dedicated attorneys representing diverse international clients in many industries who turn to us for a wide range of legal services and resources. Our offices are located in Boston, Washington, D.C., New York, San Diego, Los Angeles, San Francisco, Stamford (CT), and London. Our clients include:

gsk - (GlaxoSmithKline) - We are a science-led global healthcare company. We have a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world.

Millenium / Takeda - Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company.

Coca-Cola Company - The world is changing all around us. To continue to thrive as a business over the next ten years and beyond, we must look ahead, understand the trends and forces that will shape our business in the future and move swiftly to prepare for what's to come. We must get ready for tomorrow today. 

Amgen - Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A leader in biotechnology since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses.

AstraZeneca - As a global biopharmaceutical company, our activities touch many people’s lives. For patients and physicians, we provide medicines for some of the world’s most serious diseases. For the people who pay for healthcare, we work to make sure that our medicines offer real value for money. 

Baxter U.S. - Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2011 sales of $13.9 billion and has approximately 48,500 employees.

Genentech - Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 35 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.

Biogen Idec - Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. We are the world's oldest independent biotechnology company and a Fortune 500 company with more than $5 billion in revenues. Patients worldwide benefit from our products.

Forest Laboritories - Forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems, and we are always exploring new product opportunities that address a range of health conditions. Our principal brands include Bystolic® (nebivolol), Daliresp® (roflumilast), Lexapro® (escitalopram oxalate), Namenda® (memantine HCl), Savella®(milnacipran HCl), Teflaro® (ceftaroline fosamil) for injection, and Viibryd® (vilazodone HCl).

Genzyme - Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before.

Illinois: Putting Science to Work 

Illinois Science & Technology Coalition - The Illinois Science & Technology Coalition will cultivate innovation and technology-based economic development in Illinois.  As the only organization representing the full range of science and technology activity in Illinois, our mission is to cultivate innovation and technology-based economic development in Illinois...

Monsanto - The Monsanto Pledge is our commitment to how we do business. It is a declaration that compels us to listen more, to consider our actions and their impact broadly, and to lead responsibly. It helps us to convert our values into actions, and to make clear who we are and what we champion. -click through here for the rest of the pledge. 

Novartis - We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.

Daiichi Sankyo Co., LTD. - Pharmaceutical innovation and therapeutic advances have had a dramatic impact on the lives of millions of people the world over.

Novozymes - Biotechnology from Novozymes equals rethinking tomorrow Novozymes is a biotech company with a strong focus on enzyme production. We are committed to changing the very foundations of our industrial system for the better by using industrial biotechnology. As a leading biotech company we believe that by using industrial biotechnology we can potentially re-engineer thousands of everyday products to deliver enhanced sustainability performance, at no extra cost. It is a compelling proposition, but one backed by strong evidence. 

Lilly - Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity and respect for people. 

Merck - Be Well. From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world. Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer health and animal products.  We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow. 

Sanofi Pasteur - Sanofi Pasteur offers the broadest range of vaccines in the world, protecting against 20 bacterial and viral diseases. Combination vaccines, those that protect against multiple diseases, are one of the strengths of sanofi pasteur's product range. They offer the advantage of simplifying vaccination schedules, decreasing the number of injections and the health-related costs. - via World Health Organization

SNR Denton - SNR Denton is a client-focused international legal practice delivering quality and value.  
We serve clients in key business and financial centers from more than 60 locations worldwide, through offices, associate firms and special alliances across the US, the UK, Europe, the Middle East, Russia and the CIS, Asia Pacific and Africa, making us a top 25 legal services provider by lawyers and professionals.  
UCB A global biopharma focused on severe diseases with operations in about 40 countries and global revenue of € 3.2 billion in 2011. We combine biology and chemistry to make major breakthroughs. By integrating our expertise in large, antibody-based molecules and small, chemically-derived molecules, we can offer families with severe diseases and their specialist physicians the advantages of both large and small molecules to produce extraordinary breakthroughs.

EMD Soreno Inc. - EMD Serono, Inc. is a leader in the U.S. biopharmaceutical industry. We have more than 1,000 employees throughout the United States with fully integrated commercial, clinical, and research operations near Boston and headquarters in Rockland, Massachusetts. EMD Serono has more than 30 trials in our global clinical pipeline, focused on developing innovative therapies for cancer and neurodegenerative diseases such as multiple sclerosis and Parkinson's disease.

WilmerHale - LEGAL EXCELLENCE. DEDICATION TO CLIENTS. COMMITMENT TO PUBLIC SERVICE. WilmerHale offers unparalleled legal representation across a comprehensive range of practice areas that are critical to the success of our clients. We practice at the very top of the legal profession and offer a cutting-edge blend of capabilities that enables us to handle deals and cases of any size and complexity. Today, businesses face greater scrutiny and more “bet the company” issues than ever before. With a practice unsurpassed in depth and scope by any other major firm, we have the ability to anticipate obstacles, seize opportunities and get the case resolved or the deal done—and the experience and know-how to prevent it from being undone.

Alexandria - (ARE) Alexandria Real Estate Equities - Alexandria Real Estate Equities Inc. (NYSE: ARE) is the world's leading investment-grade real estate investment trust (REIT) focused principally on owning, operating, and developing real estate for the life science industry.

Alkermes - Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.

Allergan - From diverse strengths come important new therapies that make a real difference. Allergan is a global, technology-driven multi-specialty health care company pursuing therapeutic advances to help patients live life to their fullest potential. In making this commitment, we work to develop an unparalleled level of insight into patients' wants and needs — and into the priorities and concerns of the medical specialists who treat them. To this end, we employ more than 50 percent of our work force in either research and development (R&D) or sales, ensuring our efforts are focused on innovation and our customers.

Alnylam - Alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as RNA interference, or RNAi. With RNAi technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.

Bayer HealthCare - The Company combines the global activities of the divisions Animal Health, Pharmaceuticals, Consumer Care and Medical Care. More than 50,000 people are employed by Bayer HealthCare worldwide. Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease.

Bayer Crop Science - Bayer CropScience is with annual sales of about EUR 6.8 billion one of the world's leading innovative cropscience companies in the area of crop protection (Crop Protection), non agricultural pest-control (Environmental Science), seeds and plant biotechnology (BioScience).

BioMed Realty Trust, Inc - BioMed Realty Trust, Inc. is a fully integrated, self-administered and self-managed real estate investment trust (REIT) that commenced operations following its initial public offering in August 2004. BioMed is an entrepreneurial company focused on Providing Real Estate to the Life Science Industry®. With over $4.2 billion invested in state-of-the-art research facilities, we have assembled a world-class portfolio of life science buildings concentrated in the seven core U.S. life science markets of Boston, San Francisco, Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle.

Boehringer Ingelheim - A successful and independent Corporation. Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes. 

Bristol-Myers Squibb - Bristol-Myers Squibb is a global BioPharma company firmly focused on its Missionto discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Burrill & Company - Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With $1.5 billion in assets under management, the firm's businesses include venture capital/private equity, merchant banking, and media. By leveraging the scientific and business networks of its team, Burrill & Company has established unrivaled access and visibility in the life sciences industry.

Chubb Group of Insurance Companies - For nearly 130 years, the Chubb Group of Insurance Companies has been delivering exceptional property and casualty insurance products and services to businesses and individuals around the world.

Ernst & Young - Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 152,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.

Foley Hoag - Foley Hoag’s commitment to advance and protect its clients’ interests has made it the go-to law firm for a wide array of emerging, middle market, and large-cap companies. Our strength lies in our deep understanding of our clients’ businesses and industries, of their strategic priorities and operational imperatives, and of the marketplace realities that shape their business interests. These strengths provide our clients with distinct competitive advantages.

Bio Maryland - The staff of the Maryland Biotechnology Center draws upon years of experience in the bioscience industry, academia, federal laboratories and economic development.  We are highly dedicated to help you acquire the knowledge and information you need to successfully connect your company to Maryland's resources and opportunities. Through our programs and services we aim to provide you with the tools you require to bring an idea to market or your research to reality.

Vertex - Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives. Vertex scientists and our collaborators are working on new medicines to advance the treatment of hepatitis C, cystic fibrosis, epilepsy and other life-threatening diseases.


  1. This comment has been removed by a blog administrator.

  2. This comment was removed because it was spam.